# Anti-HIV Medications for People Recently Infected With HIV

> **NCT00106171** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins Bloomberg School of Public Health** · enrollment: 113 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Highly active antiretroviral therapy (HAART)

## Key facts

- **NCT ID:** NCT00106171
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2023-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106171, "Anti-HIV Medications for People Recently Infected With HIV". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00106171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
